Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994
Drug Therapy of Migraine
NEJM 329:1476-1483, Welch,K.M.A., 1993
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
Sumatriptan
Lancet 341:221-224, Bateman,D.N., 1993
Sumatriptan and Chest Pain
Lancet 341:1564-1565, Hillis,W.S.&MacIntyre,P.D., 1993
Transmural Myocardial Infarction with Sumatriptan
Lancet 341:861-862, Ottervanger,J.P.,et al, 1993
Efficacy of Subcutaneous Sumatriptan in Repeated Episodes of Migraine
Neurol 43:1363-1368, Cady,R.K.,et al, 1993
A Novel Antineuronal Antibody in Stiff-Man Syndrome
Neurol 43:114-120, Darnell,R.B.,et al, 1993
Postmarketing Study of Cardiovascular Adverse Reactions Associated with Sumatriptan
BMJ 307:1185, Ottervanger,J.P.,et al, 1993
Treatment of Migraine
Lancet 339:1207-1209, Lance,J.W., 1992
Coronary Vasospasm Induced by Subcutaneous Sumatriptan
BMJ 304:1415, Willett,F.,et al, 1992
Sumatriptan
Serotonin, Migraine, and Money, Editorial, Lancet 339:151-1522., , 1992
Do NMDA Antagonists Prevent Neuronal Injury? Yes
ARch Neurol 49:418-420, Albers,G.W.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? No
Arch Neurol 49:420-421, Buchan,A.M., 1992
Sumatriptan for Migraine
The Medical Letter, 34:91-931992., , 1992
Dose Ranging Efficacy & Safety of Subcut Sumatriptan in Acute Treat of Migraine
Arch Neurol 49:1271-1276, Mathew,N.T.,et al, 1992
Sumatriptan:Efficacy and Contribution to Migraine Mechanisms
JNNP 55:1103-1105, Pearce,J.M.S., 1992
Oral Sumatriptan in Acute Migraine
Lancet 338:782-783, Goadsby,P.J.,et al, 1991
Migraine-Related Stroke in Childhood
Lancet 337:825-826, , 1991
Treatment of Acute Migraine with Subcutaneous Sumatriptan
JAMA 265:2831-2835, Cady,R.K.,et al, 1991
Treatment of Migraine Attacks with Sumatriptan
The Subcutaneous Sumatriptan International Study Group, NEJM 325:316-321, 353-354991., , 1991
Migraine Pain Associated with Middle Cerebral Artery Dilatation:Reversal by Sumatriptan
Lancet 338:13-17, Friberg,L.,et al, 1991
Treatment of Acute Cluster Headache with Sumatriptan
The Sumatriptan Cluster Headache Study Group, NEJM 325:322-326, 353-354991., , 1991
N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Sumatriptan in Migraine, May be Better than Aspirin and Metoclopramide
BMJ 303:1491, Pearce,J.M.S., 1991
Autoantibodies to Gaba-Ergic Neurons & Pancreatic Beta Cells in Stiff-Man Syndrome
NEJM 322:1555-1560, Solimena,M.,et al, 1990
Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989
Possible Benefit of GR43175, A Novel 5-HT1-Like Receptor Agonist for the Acute Treatment of Severe Migraine
Lancet 1:1309-1311, Doenicke,A.,et al, 1988
Autoantibodies to Glutamic Acid Decarboxylase in Pt with Stiff-Man Syndr, Epilepsy & Type I Diabetes Mellitus
NEJM 318:1012-1020, Solimena,M.,et al, 1988
Polymyalgia Rheumatica
NEJM 394:1097-1109, Dejaco,C.,et al, 2026
Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia
Neurol 106:e214933, van Steenhoven,R.W.,et al, 2026
High-Grade Gliomas with Autoimmune Encephalitis-Like Presentation: Case Report and Systematic Review of the Literature
Neurological Sci 46:3559-3572, Creda,G.S.et al, 2025
A 72-Year-Old Man with Progressive Pan-Dysautonomia
Neurol 105:e213994, Zelikovich,A.S.,et al, 2025
A Woman with Subacute Progression of Distal Upper Extremity Weakness
Neurol 105:e214212, Zhao,A.J.,et al, 2025
Neuroimaging Findings in Children and Young Adults with Neurotoxicity after CAR T-Cell Therapy for B-Cell Malignancies
Neurol 105:e214086, McGuire,J.L.,et al, 2025
A 66-Year-Old Man with Chronic Orthostatic Hypotension
Neurol 105:e214294, Lenka,A. & Vernino,S, 2025
Myelin Oligodendrocyte Glycoprotein Antibody - Associated Cerebral Cortical Encephalitis: A Case Report Highlighting Diagnostic Challenges and Therapeutic Implications
Front Immunol 16:1619807, Liu,M. & Li, D., 2025
Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice
Neurol 104:e213498, Zara,P.,et al, 2025
A 60-Year-Old Man with Rapidly Progressive Left Hemibody Weakness and Vision Loss
Neurol 105: e213869, Rock,M.,et al, 2025
Neuroleptic Malignant Syndrome
NEJM 391:1130-1138, Wijdicks,E.F.M. & Ropper,A.H., 2024
Clinicopathologic Conference, Myasthenia Gravis
NEJM 391:1441-1450, Case 32-2024, 2024
Vitamin B12 Deficiency:NICE Guideline Summary
BMJ 385:q1019, q1262, Sands,T.,et al, 2024
MR Imaging Findings in Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis:A Systematic Review and Meta-Analysis
AJNR 45:977-986, Almeida,F.C.,et al, 2024
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Ann Neurol 96:21-33, Gilligan,M.,et al, 2024
Clinicopathologic Conference, Paraneoplastic Encephalomyelitis Due to Small-Cell Lung Carcinoma and Concurrent Cerebral Amyloid Angiopathy
NEJM< 391357-369, Case 23-2024, 2024
Repurposing Erectile Dysfunction Medication for Alzheimer Disease Prevention
Neurol 102:e209180, Yasara,S., & Nidadavolu,L., 2024
Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis
Neurol 102:e209245, Togni,C.L.,et al, 2024